Nordicus Partners Corporation

Nordicus Partners Corporation

NORD - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$54.63M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nordicus Partners CorporationNordicus Partners Corporation-9.2--5%--
$0.00

Current Fair Value

100% downside

Overvalued by 100% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$54.63 Million
Enterprise Value$54.70 Million
Earnings per Share$-0.22
Beta-0.7
Outstanding Shares19,167,467

Return

Return on Equity-4.54%ROE
Return on Assets-3.82%
Return on Invested Capital-6.28%

Valuation & Multiples

P/E Ratio-9.2P/E Ratio
PEG9.19PEG
Price to Sales-Price to Sales
Price to Book Ratio0.95Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-12.2
Enterprise Value to Net Income-20
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 13, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Nordicus Partners Corporation

15 employees
CEO: Henrik Rouf

Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus fo...